The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis
Open accessAbstract
Sweet's syndrome (the eponym for acute febrile neutrophilic dermatosis) is characterized by a constellation of clinical symptoms, physical features, and pathologic findings which include fever, neutrophilia, tender erythematous skin lesions (papules, nodules, and plaques), and a diffuse infiltrate consisting predominantly of mature neutrophils that are typically located in the upper dermis. Several hundreds cases of Sweet's syndrome have been published. Sweet's syndrome presents in three clinical settings: classical (or idiopathic), malignancy-associated, and drug-induced. Classical Sweet's syndrome (CSS) usually presents in women between the age of 30 to 50 years, it is often preceded by an upper respiratory tract infection and may be associated with inflammatory bowel disease and pregnancy. Approximately one-third of patients with CSS experience recurrence of the dermatosis. The malignancy-associated Sweet's syndrome (MASS) can occur as a paraneoplastic syndrome in patients with an established cancer or individuals whose Sweet's syndrome-related hematologic dyscrasia or solid tumor was previously undiscovered; MASS is most commonly related to acute myelogenous leukemia. The dermatosis can precede, follow, or appear concurrent with the diagnosis of the patient's cancer. Hence, MASS can be the cutaneous harbinger of either an undiagnosed visceral malignancy in a previously cancer-free individual or an unsuspected cancer recurrence in an oncology patient. Drug-induced Sweet's syndrome (DISS) most commonly occurs in patients who have been treated with granulocyte-colony stimulating factor, however, other medications may also be associated with DISS. The pathogenesis of Sweet's syndrome may be multifactorial and still remains to be definitively established. Clinical and laboratory evidence suggests that cytokines have an etiologic role. Systemic corticosteroids are the therapeutic gold standard for Sweet's syndrome. After initiation of treatment with systemic corticosteroids, there is a prompt response consisting of dramatic improvement of both the dermatosis-related symptoms and skin lesions. Topical application of high potency corticosteroids or intralesional corticosteroids may be efficacious for treating localized lesions. Other first-line oral systemic agents are potassium iodide and colchicine. Second-line oral systemic agents include indomethacin, clofazimine, cyclosporine, and dapsone. The symptoms and lesions of Sweet's syndrome may resolved spontaneously, without any therapeutic intervention; however, recurrence may follow either spontaneous remission or therapy-induced clinical resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Fitzpatrick's Dermatology in General Medicine.
Cox, N. H. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.6032_1.x · Cited by 1,176
AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS.
SWEET, R. B. (1964) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1964.tb14541.x · Cited by 1,049
Sweet's syndrome (acute febrile neutrophilic dermatosis)
Driesch, P. V. D. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70215-2 · Cited by 655
Histologic Diagnosis of Inflammatory Skin Diseases.
(1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-6-1001_3 · Cited by 608
[Sweet's syndrome. Acute febrile neutrophilic dermatosis].
Bt, G., & Holm, J. O. (1987) · PubMed · Cited by 504
Walker, D. C., & Cohen, P. R. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90080-8 · Cited by 338
Self-citationSmith, R. A., Cokkinides, V., & Eyre, H. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.90 · Cited by 293
Kawakami, T., Ohashi, S., Kawa, Y., Takahama, H., Ito, M., Soma, Y., & Mizoguchi, M. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.5.570 · Cited by 154
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Van Assche, G., Dignass, A., Reinisch, W., van der Woude, C. J., Sturm, A., De Vos, M., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 894
Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment
Pelosof, L. C., & Gerber, D. E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0099 · Cited by 773
Van Assche, G., Dignass, A., Bokemeyer, B., Danese, S., Gionchetti, P., Moser, G., Beaugerie, L., Gomollón, F., Häuser, W., Herrlinger, K., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.005 · Cited by 463
Larsen, S., Bendtzen, K., & Nielsen, O. H. (2010) · Annals of Medicine · doi:10.3109/07853890903559724 · Cited by 303
Metadata
- Authors
- Cohen, P. R.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2007-07-26
- Volume
- 2
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W2126086393
- Cited by
- 879
- References
- 38
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. https://app.cochat.ai/papers/10.1186/1750-1172-2-34
- The paper
- Cohen, P. R. (2007). Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-2-34
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.